US 10471142
Combination therapy using immunoglobulin and C1-Inhibitor
granted A61KA61K2039/505A61K38/55
Quick answer
US patent 10471142 (Combination therapy using immunoglobulin and C1-Inhibitor) held by THE GOVERNMENT OF THE UNITED STATES OF AMERICA expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE GOVERNMENT OF THE UNITED STATES OF AMERICA
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K38/55, A61K38/57, A61K39/39516